AquaBounty Technologies (NASDAQ:AQB) Shares Climb 7.8% – Time to Buy?

Posted by Dante Gardener on Oct 10th, 2026

Shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Get Free Report) rose 7.8% on Friday. The stock traded as high as $1.09 and last traded at $1.05. Approximately 110,233 shares were traded during trading, an increase of 15% from the average session volume of 95,446 shares. The stock had previously closed at $0.9742.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, September 14th. One equities research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, AquaBounty Technologies presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on AQB

AquaBounty Technologies Trading Up 7.8%

The stock has a market capitalization of $5.41 million, a price-to-earnings ratio of -1.28 and a beta of 1.48. The firm has a 50-day moving average of $1.14 and a 200-day moving average of $1.03.

AquaBounty Technologies (NASDAQ:AQB – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.26) EPS for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in AquaBounty Technologies stock. BlackRock Inc. purchased a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 47,528 shares of the company’s stock, valued at approximately $51,000. BlackRock Inc. owned 0.92% of AquaBounty Technologies as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 8.92% of the company’s stock.

About AquaBounty Technologies

(Get Free Report)

AquaBounty Technologies, Inc is a biotechnology and aquaculture company focused on developing land-based, land-based recirculating aquaculture systems (RAS) to produce Atlantic salmon. The company’s approach is designed to support year-round fish production while reducing reliance on ocean-based farming and limiting water use through treatment and reuse.

AquaBounty’s principal product is AquAdvantage salmon, a genetically engineered Atlantic salmon developed to reach market size more efficiently than conventional Atlantic salmon.